Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:brand
gptkb:drug |
| gptkbp:activeIngredient |
gptkb:vorinostat
|
| gptkbp:approvalYear |
2006
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
gptkb:L01XX43
|
| gptkbp:CASNumber |
149647-78-9
|
| gptkbp:chemicalFormula |
C14H20N2O3
|
| gptkbp:drugClass |
histone deacetylase inhibitor
|
| https://www.w3.org/2000/01/rdf-schema#label |
Zolinza
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Merck_&_Co.
|
| gptkbp:mechanismOfAction |
inhibits histone deacetylases
|
| gptkbp:pregnancyCategory |
D (US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
diarrhea anorexia fatigue thrombocytopenia |
| gptkbp:usedFor |
leukemia
|
| gptkbp:bfsParent |
gptkb:Merck_&_Co.
|
| gptkbp:bfsLayer |
4
|